Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

1.180 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2026 Add to My Watchlist

Price and Volume

Volume	212
Open	1.180
Bid (Size)	1.140 (3,000)
Ask (Size)	1.200 (100)
Prev. Close	1.180
Today's Range	1.180 - 1.180
52wk Range	1.120 - 44.77
Shares Outstanding	6,297,303
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

March 24, 2026

Via ACCESS Newswire

Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

March 19, 2026

Via ACCESS Newswire

Performance

YTD	-63.7%	-63.7%
1 Month	-15.1%	-15.1%
3 Month	-66.1%	-66.1%
6 Month	-80.1%	-80.1%
1 Year	-96.6%	-96.6%

More News

Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025

February 26, 2026

Via ACCESS Newswire

The trading volume of these stocks is deviating from the norm in today's session. ↗

January 26, 2026

Via Chartmill

REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year ↗

January 26, 2026

Via Stocktwits

American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements

January 26, 2026

Via AB Newswire

What's going on in today's session ↗

January 23, 2026

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

January 23, 2026

Via Chartmill

Which stocks are moving on Friday? ↗

January 23, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Friday. ↗

January 23, 2026

Via Chartmill

Thursday's session: top gainers and losers ↗

January 22, 2026

Via Chartmill

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

January 21, 2026

Via ACCESS Newswire

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

January 14, 2026

Via ACCESS Newswire

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 12, 2026

Via ACCESS Newswire

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

January 07, 2026

Via ACCESS Newswire

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

December 01, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 20, 2025

Via Benzinga

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

November 20, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 10, 2025

Via Benzinga

REVELATION BIOSCIENCES INC (NASDAQ:REVB) Reports Q3 2025 Loss, Announces Groundbreaking Clinical Data and Improved Cash Runway ↗

November 06, 2025

Via Chartmill

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

November 06, 2025

Via ACCESS Newswire

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

October 29, 2025

Via ACCESS Newswire

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

October 15, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 11, 2025

Via Benzinga

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

September 11, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Revelation Biosciences, Inc. - Common Stock publicly traded?

Yes, Revelation Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Revelation Biosciences, Inc. - Common Stock trade on?

Revelation Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Revelation Biosciences, Inc. - Common Stock?

The ticker symbol for Revelation Biosciences, Inc. - Common Stock is REVB on the Nasdaq Stock Market

What is the current price of Revelation Biosciences, Inc. - Common Stock?

The current price of Revelation Biosciences, Inc. - Common Stock is 1.180

When was Revelation Biosciences, Inc. - Common Stock last traded?

The last trade of Revelation Biosciences, Inc. - Common Stock was at 03/25/26 04:00 PM ET

What is the market capitalization of Revelation Biosciences, Inc. - Common Stock?

The market capitalization of Revelation Biosciences, Inc. - Common Stock is 7.43M

How many shares of Revelation Biosciences, Inc. - Common Stock are outstanding?

Revelation Biosciences, Inc. - Common Stock has 7M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.